Clinical Trial Update: Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating donor-specific immune senescence and exhaustion as biomarkers of tolerance after liver transplantation has completed, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant
• Liver Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Liver Transplant, Liver Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2021-03-05